Seshadri Neervannan

Chief Operating Officer

Chief Operating Officer at Tarsus Pharmaceuticals, Inc., filing insider transactions between 2026-03-04 and 2026-03-20.

Total Purchases

—

0 transactions

Total Sales

$1.6M

5 transactions

Companies Traded

5 total filings

Active Since

2026-03-04

Last: 2026-03-20

Companies

Tarsus Pharmaceuticals, Inc.

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-03-20	TARS	Sale	2,989	$66.75	$200K	82.8K	SEC ↗
2026-03-19	TARS	Sale	4,589	$67.00	$307K	85.8K	SEC ↗
2026-03-18	TARS	Sale	3,610	$68.71	$248K	90.4K